MASK (Mobile Airways Sentinel Network), as part of the Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, involves more than 22 countries worldwide. It works closely with POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) and collaborates with professional and patient organizations in the field of allergies and respiratory diseases.

MASK offers real-world care pathways focused on the patients with rhinitis and/or multimorbidity asthma.

CIRFF actively participates in the ARIA in the PHARMACY working group, which aims to develop and study the use of digital devices for respiratory diseases in the community pharmacy setting.

Available results:

• Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022. Clinical and Translational Allergy

• Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air^® approach. Clinical and Translational Allergy

• Active and Healthy Living in the Digital World. Futurium

• 2019 ARIA Care pathways for allergen immunotherapy. European Academy of Allergy and Clinical Immunology

• ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”. European Academy of Allergy and Clinical Immunology

• Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clinical and Translational Allergy

• Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology

• MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy

• Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study. Journal of Allergy and Clinical Immunology

• The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Journal of Allergy and Clinical Immunology